21 research outputs found
CENTRAL OBESITY SEEMS TO HAVE THE HIGHEST PREDICTIVE VALUE AMONG ALL OTHERS ANTHROPOMETRIC INDICES FOR THE FIVE-YEAR INCIDENCE OF HYPERTENSION IN APPARENTLY HEALTHY INDIVIDUALS: THE ATTICA STUDY
Statins in Stroke
Background: Stroke is a major cause of mortality and disability in modem
societies. Statins are effective medications in decreasing
cardiovascular events through lipid lowering and pleiotropic effects.
Objective: To summarize current evidence regarding the role of statins
in the prevention and management of stroke.
Methods: A narrative review of current evidence regarding the effect of
statins in stroke management. Electronic searches of MEDLINE, EMBASE and
Cochrane Databases were performed.
Results: In primary prevention of stroke in patients with risk factors
but no established cardiovascular disease, potent statins such as
atorvastatin and rosuvastatin have shown some benefits, but the clinical
relevance of this effect is questionable. In populations at higher risk
of stroke, such as patients with established coronary heart disease, the
majority of relevant studies have shown a beneficial effect of statins
in preventing stroke. Similarly, in patients with a previous
cerebrovascular event, there is a clear benefit of statins for the
prevention of recurrent events. The use of statins is not associated
with an increased risk of intracranial bleeding in primary prevention
studies. There may be an increased incidence of non-fatal hemorrhagic
stroke with high dose statins in patients with a previous
cerebrovascular event. Patients who experience a stroke while on statins
should not discontinue statins. In addition, statins are associated with
better survival and improved functional outcome when administered during
the acute phase of stroke in statin-naive patients. In contrast, statins
do not confer any benefit in patients with acute ischemic stroke who
receive thrombolysis.
Conclusion: Treatment with statins prevents ischemic stroke, especially
in patients with high cardiovascular risk and established
atherosclerotic disease. It seems that both lipid lowering and
pleiotropic effects contribute to these effects
Arterial endothelial function and wall thickness in familial hypercholesterolemia and familial combined hyperlipidemia and the effect of statins. A systematic review and meta-analysis
Background: To evaluate the impact of familial hypercholesterolemia (FH)
and familial combined hyperlipidemia (FCH) on arterial properties and
the effects of statins.
Methods: We meta-analyzed 51 studies providing data for 4,057 FH
patients and 732 FCH patients with random-effects models,
meta-regression analysis and publication bias analysis. The main
outcomes of interest were (1) brachial artery flow-mediated dilation
(FMD), (2) intima-media thickness (IMT), and (3) change of IMT and FMD
after treatment with statins.
Results: Compared to normolipidemic controls, FH patients had lower FMD
[pooled mean difference (MD): 5.31%, 95% CI 7.09 to 3.53%, P <
0.001] and higher carotid IMT (pooled MD: 0.12 mm, 95% CI 0.09-0.15 mm,
P < 0.001) and femoral IMT (pooled MD: 0.35 mm, 95% CI 0.18-0.51 mm, P
< 0.001). FCH patients had lower FMD and increased IMT (pooled MD:
-3.60%, 95% CI -6.69 to -0.50%, P = 0.023; and 0.06 mm, 95% CI
0.04-0.08 mm, P < 0.001, respectively). Total and LDL-cholesterol was a
significant determinant of FMD and carotid IMT in FCH patients and of
FMD and femoral IMT in FH patients. In FH patients, statins improved FMD
(pooled MD of change: 5.39%, 95% CI 2.86-7.92%, P < 0.001) and
decreased carotid IMT (pooled MD of change: -0.025 mm, 95% CI -0.042 to
-0.009 mm, P = 0.003). Changes of both FMD and IMT with statins
correlated with the duration x treatment intensity product in FH
patients (both P < 0.01). Additionally, statins improved FMD in FCH
patients (pooled MD of change: 2.06%, 95% CI 0.43-3.69%, P = 0.013).
No significant publication bias was detected.
Conclusion: Arterial properties are impaired in subjects with FH or FCH.
Statins improve arterial function and structure in FH patients in a
treatment intensity-related manner. (C) 2010 Elsevier Ireland Ltd. All
rights reserved
Subclinical Left Ventricular Systolic Dysfunction in HIV Patients: Prevalence and Associations with Carotid Atherosclerosis and Increased Adiposity
Background: Human immunodeficiency virus (HIV) is mainly detected in young, otherwise healthy, individuals. Cardiomyopathy and peripheral artery disease affecting these patients appears to be multifactorial. Prompt and potentially more effective implementation of therapeutic measures could be enabled by pre-symptomatic diagnosis of myocardial dysfunction and peripheral artery damage. However, limited data is available to date on this specific topic. Μethods: We investigated the association between global longitudinal strain (GLS), an established index of subclinical left ventricular systolic dysfunction (LVSD) assessed by two-dimensional speckle-tracking echocardiography, and: (a) patient history; (b) demographic and clinical baseline characteristics; (c) carotid intima-media thickness (IMT) and the presence of carotid atherosclerotic plaque(s), measured by ultrasonography; (d) temperature difference (ΔT) along each carotid artery, measured by microwave radiometry; and (e) basic blood panel measurements, including high-sensitivity troponin-T (hsTnT) and NT-proBNP in people living with HIV (PLWH) and no history of cardiovascular disease. Results: We prospectively enrolled 103 consecutive PLWH (95% male, age 47 ± 11 years, anti-retroviral therapy 100%) and 52 age- and sex-matched controls. PLWH had a significantly higher relative wall thickness (0.38 ± 0.08 vs. 0.36 ± 0.04, p = 0.048), and higher rate of LVSD (34% vs. 15.4%, p = 0.015), and carotid artery atherosclerosis (28% vs. 6%, p = 0.001) compared with controls. Among PLWH, LVSD was independently associated with the presence of carotid atherosclerosis (adj. OR:3.09; 95%CI:1.10–8.67, p = 0.032) and BMI (1.15; 1.03–1.29, p = 0.017), while a trend for association between LVSD and left ventricular hypertrophy was also noted (3.12; 0.73–13.33, p = 0.124). No differences were seen in microwave radiometry parameters, NT-proBNP, hs-TnT and c-reactive protein between PLWH with and without LVSD. Conclusions: Subclinical LVSD and carotid atherosclerosis were significantly more frequent in PLWH compared to a group of healthy individuals, implying a possible link between HIV infection and these two pathological processes. Carotid atherosclerosis and increased adiposity were independently associated with impaired GLS in HIV-infected individuals
STRUCTURAL AND FUNCTIONAL CAROTID ARTERIAL MARKERS SHOW SIMILAR PREDICTIVE ACCURACY FOR THE PRESENCE AND OF EXTENT CORONARY ARTERY DISEASE
Morphological and Functional Assessment of Carotid Plaques Have Similar Predictive Accuracy for Coronary Artery Disease
Background and Purpose Microwave radiometry allows noninvasive in vivo
measuring of internal temperature of tissues reflecting inflammation. In
the present study, we evaluated the predictive accuracy of this method
for the diagnosis of coronary artery disease (CAD).
Methods Consecutive patients (n=287) scheduled for coronary angiography
were included in the study. In carotid arteries of both groups, the
following measurements were performed: (1) intima-media thickness
(IMTmax) and (2) temperature measurements by microwave radiometry
(T-max). C-statistic and net reclassification improvement were used to
compare the prediction ability of the markers IMTmax and T-max for the
presence of CAD and multivessel CAD.
Results Of 287 patients, 239 had stenoses 50% (CAD group), and 48 did
not have significant stenoses (NO-CAD group). T-max was an independent
predictor for the presence of CAD and multivessel CAD, showing similar
predictive accuracy to intima-media thickness, as assessed by
c-statistic and net reclassification improvement.
Conclusions Local inflammatory activation, as detected by microwave
radiometry, has similar predictive accuracy to intima-media thickness
for the presence and extent of CAD
MORPHOLOGICAL AND FUNCTIONAL CHARACTERISTICS OF CAROTID ARTERIES SHOW SIMILAR ACCURACY IN THE PREDICTION OF MULTIVESSEL CORONARY ARTERY DISEASE
Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaernic subjects
Aims Recent studies suggest an association between acute inflammation
and deterioration of arterial function. The effect of acute inflammation
on endotheliat function and the rote of treatment with statins have not
been investigated in subjects with dystipidaemia.
Methods and results In this randomized, placebo-controlled, double-blind
study, we generated a transient systemic inflammation by Salmonella
typhi vaccination in 50 volunteers with mild hypercholesterotaemia after
4 days of treatment with atorvastatin 40 mg or placebo once daily.
Endothelium-dependent flow-mediated dilation (FMD) of the brachial.
artery and circulating levels of endothelial, and inflammatory markers
were measured before and 8 h after the vaccine. Vaccination produced a
decline on FMD at 8 h (absolute decrease of 2.55%, P = 0.001),
indicating an unfavourable effect on endotheliat function. In contrast,
in atorvastatin-treated subjects, FMD was preserved after vaccination
(decrease of 0.15%, P = 0.005 vs. placebo). The vaccination-induced
decline in plasma level of nitric oxide metabolites (by 6.0 mu mol/L, P
= 0.007) and antioxidant capacity (by 20.6 mu mol/L, P = 0.001) in the
placebo group were completely abolished by atorvastatin (P = 0.038 and P
= 0.005, respectively, vs. placebo). In contrast, atorvastatin had no
significant effect on cytokine levels.
Conclusion Acute inflammation is aetiologically associated with the
deterioration of vasomotor and systemic endotheliat function in
hypercholesterolaemic patients. Atorvastatin effectively abrogates these
deleterious effects